| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |